Gene Expression Market Profiles for Affymetrix, Agilent, Bio-Rad Laboratories and others Analyzed

Analysts forecast the Global Gene Expression market to grow at a CAGR of 11.12 percent over the period 2014-2019.

Gene expression is the biological process where genetic information is used for the synthesis of a functional gene product, either RNA or protein. Gene expression products allow researchers to study gene expression and its impact on cell function. Researchers use gene expression profiling and analysis for various applications in the areas of drug discovery and development, clinical diagnostics, and other research purposes. Advanced PCR, NGS, and DNA microarray technology allow profiling and analysis of thousands of genes in a very short period with great accuracy and reproducibility.

This report covers the present scenario and the growth prospects of the Global Gene Expression market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of gene expression products including consumables, instruments, and services. It has a wide range of applications in various fields such as

• Drug discovery and development
• Clinical diagnostics
• Research
• Others

It also includes various gene expression technologies used in research, drug development, and diagnostics such as

• PCR
• NGS
• DNA Microarray
• Others

Global Gene Expression Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Gene Expression market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Single User License of the Report is Available at USD 3000, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=29362 .

Worldwide Transfection Technologies Industry Trends Challenges and Key Vendors Analysis Report 2018

Analysts forecast the Global Transfection Technologies market to grow at a CAGR of 8.71 percent over the period 2014-2019.

Transfection technology is used for the introduction of nucleic acids into desired cells. The process enables the expression of desired proteins in efficient cells. A stable transfection enables the integration of this foreign nucleic acid into the cellular DNA resulting in the expression of the desired proteins in cell lines. The process, which can be accomplished by various physical, chemical, or viral methods, can be used for potential applications such as gene therapy, protein production, and drug discovery.

This report covers the present scenario and the growth prospects and future prospects of the Global Transfection Technologies market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of different methods used in transfection inclusive of various instruments, reagents, and accessories which are used independently or as kits used for transfection.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Transfection Technologies market. In addition, the report discusses the major drivers that influence the growth of the market. The report outlines the geographical segmentation of this market with individual countries split under each region of the Americas, and the EMEA and APAC regions. Further, the report mention segmentation of market based on application and its forecast during 2014-2019. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Worldwide Organ Preservation Solutions Industry Trends Challenges and Key Vendors Analysis Report 2018

Organ preservation solutions help preserve the organs for a longer period when they are outside the living body. The preservation of organ is done for various applications such as organ transplantation purpose, and drug discovery and development. The preservation solution and preservation method play an important role in in vitro organ viability. The solution and method used depends on application, e.g., Perfadex is an ideal solution for lung preservation. The most widely used organ preservation methods are Static Cold Storage and Machine Perfusion.

Analysts forecast the Global Organ Preservation Solutions market to grow at a CAGR of 16.85 percent over the period 2013-2018.

The report recognizes the following companies as the key players in the Global Organ Preservation Solutions Market: BioLife Solutions, Dr. Franz Köhler Chemie and Xvivo Perfusion.

Other Prominent Vendors in the market are: 21st Century Medicine, BioTime, Bridge to Life , Bristol-Myers Squibb, Cell & Tissue Systems, Claris Lifesciences, CryoLife, Lifeline Scientific, Organ Recovery Systems, Preservation Solutions, Teva Pharmaceuticals Industries and ToleroTech

One major trend upcoming in this market is an increase in government and NGO initiatives, which are making efforts to encourage people to donate organs. The new guidelines and reimbursement policies make the organ donation process more transparent and easy.

Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=25582 .

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Organ Preservation Solutions market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sale of the solutions used for organ preservation.

Global Organ Preservation Solutions Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Organ Preservation Solutions market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers in the market is an increase in the incidence of organ failure. The growing prevalence of chronic diseases may result in the organ failure. The demand for organs has increased for transplantation purposes in organ failure cases.

Further, the report states that the major challenge in the market is the lack of organ donors for transplantation. The demand for organs for transplantation is high, compared to the availability of organ donors.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=25582 .

Global High Throughput Screening Market Growth Report and 2018 Forecast

High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other research applications. The high sensitivity, high speed, and easy to use supports the adoption of HTS in research and drug discovery to identify enzymes, ligands for receptors, ion-channels, or other pharmacological targets of interest. HTS is a crucial step in drug discovery for various applications such as assay development, target identification, and primary screening.

Analysts forecast the Global High Throughput Screening market to grow at a CAGR of 7.85 percent over the period 2013-2018.

The report recognizes the following companies as the key players in the Global High Throughput Screening (HTS) Market: Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corp., PerkinElmer Inc., Sigma-Aldrich Corp. and Thermo Fisher Scientific Inc.

Other Prominent Vendors in the market are: Aurora Biomed, Axxam, BD, BioFocus DPI, BioTek Instruments, BMG LABTECH, Brooks, Charles River Laboratories, Corning, DiscoveRx, Dynamic Devices, Evotec, F. Hoffmann-La Roche, Genedata, IntelliCyt, Luminex and Tecan.

One of the major trends emerging in the market is the improved automation and miniaturization of HTS techniques, which helps reduce the consumption of reagents and other chemical compounds in the tests.

Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=25151 .

Covered in this Report

This report covers the present scenario and the growth prospects of the Global HTS market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of instruments, consumables, and services used for HTS. It also includes the technologies used for HTS such as cell-based assays, LOC, uHTS, label-free technology, and bioinformatics.

Global High Throughput Screening Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global HTS market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers in the market is advances in HTS technology. The use of HTS technology and products has increased because of automation, improved accuracy, sensitivity, and robotics. Automated robotics reduces the manual handling of the samples, which helps reduce the errors.

Further, the report states that one of the major challenges in the market is the intense competition among the vendors. There are many big, medium, and small companies in the market that provide high-end instruments and other products.

Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=25151 .

Worldwide Bioactive Material Industry Trends Challenges and Key Vendors Analysis Report 2018

Bioactive materials are part of the biomaterial family and are increasingly becoming popular due to their ability to react with body fluids and tissues without having a negative impact on the human health. They are extensively used as tissue replacement and tissue repair materials in surgical procedures. Bioactive materials are manufactured from materials such as ceramics, glass, glass-ceramics, and composites. The major end-users of bioactive materials are the Medical sector, followed by the Dentistry and Cosmetics sectors. Bioactive materials are commercially available in forms such as powders and nano-powders, granules, and injectable products and coatings.

Analysts forecast the Global Bioactive Material Market to grow at a CAGR of 13.30 percent over the period 2013-2018.

The report recognizes the following companies as the key players in the Global Bioactive Material Market: Biomet Inc., DePuy Synthes Inc., Medtronic Inc., Stryker Corp. and Zimmer Holdings Inc.

Other Prominent Vendors in the market are: 3Di, Aap Implantate, Arthrex, Baxter, Berkeley, Biomatlante, Curasan, Dentsply, Heraeus Kulzer, Integra Life Science, Kyocera, Novabone, Takiron and Wright Medical.

One of the major trends in the market is the unique properties of bioactive material, making it useful in different application sectors such as hard tissue repair, soft tissue repair, and tissue engineering.

Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=23278 .

Covered in this Report
The report covers the present scenario and the growth prospects of the Global Bioactive Material market for the period 2014-2018. The Global Bioactive Material market can be segmented into three: Bioactive Glass, Bioactive Ceramics, and Composites.

Global Bioactive Material Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the APAC region, Europe, and North America; it also covers the Global Bioactive Material market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

According to the report, increase in aging population is one of the major drivers in the market. There will be an increased number of trauma, spinal and orthobiological surgeries because of the increased aging population, which will push the demand for bioactive materials.

Further, the report states that one of the main challenges that the market faces is the high cost of technology used to manufacture bioactive material. Bioactive material uses sol-gel technology for its preparation and uses in various biomedical applications, and the cost of this technology is very high.

Antioxidants Market Report 2018

Antioxidants are molecules that inhibit oxidation of other molecules. Antioxidants neutralize the effects of free radicals in the human body and protect the body from the chain of the oxidation reaction by becoming oxidized themselves. There are two types of antioxidants: natural antioxidants and synthetic antioxidants. Antioxidants find application in various industries including Synthetic Resins industry, Food and Beverage industry, Cosmetics industry, Fuel Additives industry, Animal Feed industry, and other industries.

Analysts forecast the Global Antioxidants market will grow at a CAGR of 4.71 percent over the period 2013-2018.

Covered in this Report

The Global Antioxidants market can be divided into six segments based on their applications in various end-user industries and markets: Synthetic Resins industry, Food and Beverages industry, Cosmetics industry, Fuel Additives market, Animal Feed industry, and Other industries.

Global Antioxidants Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Antioxidants market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.